Fetal erythroblastosis
MONDO:0006760A disorder of the fetus or newborn that occurs when fetal cells that are coated with IgG alloantibodies from the mother attack antigens inherited from the father. Severity can range from absence of symptoms to death.
Also known as: HDFN, erythroblastosis fetalis, hemolytic disease of the fetus or newborn, hemolytic disease of the foetus or newborn, hemolytic disease of the newborn, isoimmune hemolytic disease of the newborn
16 clinical trials for this condition and its sub-types, 7 tagged with Fetal erythroblastosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New drug could prevent Life-Threatening fetal anemia in High-Risk pregnancies
Disease control Recruiting nowThis phase 3 trial tests whether the drug nipocalimab can reduce the risk of severe anemia in unborn babies whose mothers have a condition called hemolytic disease of the fetus and newborn (HDFN). The study enrolls 120 pregnant women with a history of severe HDFN. Participants re…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New registry aims to understand anemia in newborns with blood disease
Knowledge-focused Recruiting nowThis study is a global registry that will follow 175 pregnant people whose babies are at risk for hemolytic disease of the fetus and newborn (HDFN), a condition where the mother's and baby's blood types clash, causing rapid red blood cell breakdown. Researchers will track how oft…
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC